P3‐128: COMBINATION OF BLOOD‐BASED BIOMARKERS AND NEUROPSYCHOLOGICAL ASSESSMENT ENABLES RELIABLE CLASSIFICATION OF TESTED SUBJECTS BY CONTROLS: MILD COGNITIVE IMPAIRMENT AND ALZHEIMER'S DISEASE. (1st July 2014)